Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
about
New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseRecent advances in pathogenesis, assessment, and treatment of atherosclerosisTranslational research in nephrology: chronic kidney disease prevention and public healthCellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsVascular effects of exercise training in CKD: current evidence and pathophysiological mechanismsKlotho and phosphate are modulators of pathologic uremic cardiac remodeling.Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist reviewTargeting gut microbiota: a potential promising therapy for diabetic kidney diseaseThe Gut as a Source of Inflammation in Chronic Kidney DiseaseAngiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondRenal function is associated with indicators of arsenic methylation capacity in Bangladeshi adultsSubclinical atherosclerosis measures for cardiovascular prediction in CKDEstimated glomerular filtration rate decline is a better risk factor for outcomes of systemic disease-related nephropathy than for outcomes of primary renal diseasesBaseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)Genetic determinants of myocardial dysfunction.Cardiac Imaging in Heart Failure with Comorbidities.Insights into kidney diseases from genome-wide association studies.The link between chronic kidney disease and cardiovascular disease.Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.Use of Electronic Health Data to Estimate Heart Failure Events in a Population-Based Cohort with CKD.Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data.Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veteransEffect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.The impact of antihypertensives on kidney disease.Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patientsPrevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study.Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: a cross-sectional study.Serum Gamma-Glutamyl Transferase and Ferritin Synergistically Associated with the Rate of Chronic Kidney Disease.Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis.Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comEffect of dialysis initiation timing on clinical outcomes: a propensity-matched analysis of a prospective cohort study in Korea.Genetic variants in nicotinic acetylcholine receptor genes jointly contribute to kidney function in American Indians: the Strong Heart Family Study.In vivo contrast free chronic myocardial infarction characterization using diffusion-weighted cardiovascular magnetic resonance.Triglyceride levels are closely associated with mild declines in estimated glomerular filtration rates in middle-aged and elderly Chinese with normal serum lipid levels.Disparities experienced by Aboriginal compared to non-Aboriginal metropolitan Western Australians in receiving coronary angiography following acute ischaemic heart disease: the impact of age and comorbiditiesFructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us.The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.Acute exercise-induced response of monocyte subtypes in chronic heart and renal failure.
P2860
Q26739475-4F1BE42A-066F-4FA5-84C5-6AAB2445805EQ26740304-098FDC66-48D7-4C54-91BD-20020CB02C3AQ26776395-07589B5D-38CF-4D2A-93CE-B0C5249488B0Q26798487-9D13EDF7-D5D0-4C1C-889F-730D9C2C4CF0Q26799916-D3DF4875-C597-4415-8C8E-389758E423F3Q27021802-BD8B7C5F-DE54-45B4-B146-DC7A80E9A37BQ27342649-860B1681-D64C-4F02-909F-D53D98C397DCQ28070029-32C3C3D3-38F4-44DD-81AE-D9F5B0F161C3Q28078235-CC1A52C1-AA70-433A-94A1-7A02678604A1Q28081781-6D839717-C21D-4DED-8DA4-082852FB55C5Q28088583-1B3AD5EB-3A7D-49EA-860B-EF43DF2CA41EQ28385894-761462DE-FCF6-4928-A9A8-3D424DF43AC9Q28386933-CC04EF87-4066-444B-A3D9-36260B83BF79Q28541807-CAE2BEFA-88A5-4E02-A68C-2D0CE74B1A83Q28550033-88F508C5-A8A8-411A-8426-F76135825C1AQ30240839-F445E716-23C9-47C1-812D-7296D3A2F6EDQ30248624-77D999D0-E26C-4B13-BFA9-5DCF51147F6FQ30248678-FE2EC3AD-B603-4126-8EFE-083082D1416BQ30487191-4657DB4D-0945-4C64-8B59-9174F4B2C33EQ30961976-F13E4C23-13D4-4123-B8E1-46D7A8AFAEFAQ31120758-96424A59-9588-4743-9011-0BDB73E49045Q31131772-1F30CE53-A2AC-4C20-90AE-FBF12A6A8FBCQ33556410-3F36659C-CC66-4157-AB18-C457E17F827EQ33588706-F61414E3-B2DD-4150-84AE-7E3E89CC481FQ33623532-14B36F28-9F2A-41BC-B459-3882D65B66ABQ33632021-876764D7-DF82-48DC-B176-39AA2178AB75Q33684162-3AECAA1D-2323-4D76-938F-7450AF89E94CQ33785255-DD685647-96B9-438F-81C6-F445A958462FQ33795888-390E36FC-3C4F-45B9-928B-37B997A707ABQ33808942-5594A5D6-1ECB-4318-8D55-B527C9EBDF95Q33829253-1AED2AC8-E841-44A5-8D2C-3D06C5BA925FQ33960590-DA7741F9-7475-4A16-86D4-D508446892A7Q34066686-CE4A705C-F1CF-4EBC-AB24-06FE4F6B49AAQ34150186-61D07984-7352-42F2-BA26-F278DB24981BQ34203641-A3FF9A9E-73A8-449C-BE98-CBC18151556FQ34281929-442E85CC-9F70-4907-B42D-A602BFB340B3Q34396298-6ED49B4B-3D37-4285-8EFC-C1BCC04DFE88Q34496535-624A74EA-CC96-4342-BAFB-CFEFB570EFC1Q34637342-C4DC764E-B233-42BC-AC64-7380FBF88A3CQ34813712-61D77FA5-ADEF-4418-88E7-FCA099B20B72
P2860
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
@en
type
label
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
@en
prefLabel
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
@en
P2093
P1433
P1476
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
@en
P2093
Brenda R Hemmelgarn
Chi Pang Wen
Hiddo J Lambers Heerspink
Johannes F Mann
Kunihiro Matsushita
Ricardo Correa-Rotter
Ron T Gansevoort
Tazeen H Jafar
P304
P356
10.1016/S0140-6736(13)60595-4
P407
P577
2013-05-31T00:00:00Z